These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34611630)

  • 21. Disparity in spectrum of infectious diseases between in-school and out-of-school children, adolescents, and youths in China: findings from a successive national surveillance from 2013 to 2021.
    Chen L; Wang L; Xing Y; Xie J; Su B; Geng M; Ren X; Zhang Y; Liu J; Ma T; Chen M; Ma Q; Jiang J; Cui M; Guo T; Yuan W; Song Y; Dong Y; Ma J
    Lancet Reg Health West Pac; 2023 Sep; 38():100811. PubMed ID: 37790079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Changes in Temporal Properties of Notifiable Infectious Disease Epidemics in China During the COVID-19 Pandemic: Population-Based Surveillance Study.
    Zhao X; Li M; Haihambo N; Jin J; Zeng Y; Qiu J; Guo M; Zhu Y; Li Z; Liu J; Teng J; Li S; Zhao YN; Cao Y; Wang X; Li Y; Gao M; Feng X; Han C
    JMIR Public Health Surveill; 2022 Jun; 8(6):e35343. PubMed ID: 35649394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effectiveness of governmental nonpharmaceutical interventions against COVID-19 at controlling seasonal influenza transmission: an ecological study.
    Qiu Z; Cao Z; Zou M; Tang K; Zhang C; Tang J; Zeng J; Wang Y; Sun Q; Wang D; Du X
    BMC Infect Dis; 2022 Apr; 22(1):331. PubMed ID: 35379168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonpharmaceutical interventions reduce the incidence and mortality of COVID-19: A study based on the survey from the International COVID-19 Research Network (ICRN).
    Park SH; Hong SH; Kim K; Lee SW; Yon DK; Jung SJ; Abdeen Z; Ghayda RA; Ahmed MLCB; Serouri AA; Al-Herz W; Al-Shamsi HO; Ali S; Ali K; Baatarkhuu O; Nielsen HB; Bernini-Carri E; Bondarenko A; Cassell A; Cham A; Chua MLK; Dadabhai S; Darre T; Davtyan H; Dragioti E; East B; Edwards RJ; Ferioli M; Georgiev T; Ghandour LA; Harapan H; Hsueh PR; Mallah SI; Ikram A; Inoue S; Jacob L; Janković SM; Jayarajah U; Jesenak M; Kakodkar P; Kapata N; Kebede Y; Khader Y; Kifle M; Koh D; Maleš VK; Kotfis K; Koyanagi A; Kretchy JP; Lakoh S; Lee J; Lee JY; Mendonça MDLL; Ling L; Llibre-Guerra J; Machida M; Makurumidze R; Memish ZA; Mendoza I; Moiseev S; Nadasdy T; Nahshon C; Ñamendys-Silva SA; Yongsi BN; Nicolasora AD; Nugmanova Z; Oh H; Oksanen A; Owopetu O; Ozguler ZO; Parperis K; Perez GE; Pongpirul K; Rademaker M; Radojevic N; Roca A; Rodriguez-Morales AJ; Roshi E; Saeed KMI; Sah R; Sakakushev B; Sallam DE; Sathian B; Schober P; Ali PSS; Simonović Z; Singhal T; Skhvitaridze N; Solmi M; Subbaram K; Tizaoui K; Tlhakanelo JT; Torales J; Torres-Roman JS; Tsartsalis D; Tsolmon J; Vieira DN; Rosa SGV; Wanghi G; Wollina U; Xu RH; Yang L; Zia K; Zildzic M; Il Shin J; Smith L
    J Med Virol; 2023 Feb; 95(2):e28354. PubMed ID: 36447130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spatiotemporal impact of non-pharmaceutical interventions against COVID-19 on the incidence of infectious diarrhea in Xi'an, China.
    Zhang H; Shen L; Sun M; Zhao C; Li Q; Yang Z; Liu J; Liu K; Xiao B
    Front Public Health; 2022; 10():1011592. PubMed ID: 36518571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Travel-related control measures to contain the COVID-19 pandemic: a rapid review.
    Burns J; Movsisyan A; Stratil JM; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Pfadenhauer LM; von Philipsborn P; Sell K; Voss S; Rehfuess E
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013717. PubMed ID: 33502002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Nonpharmaceutical Interventions on the Incidence of Respiratory Infections During the Coronavirus Disease 2019 (COVID-19) Outbreak in Korea: A Nationwide Surveillance Study.
    Huh K; Jung J; Hong J; Kim M; Ahn JG; Kim JH; Kang JM
    Clin Infect Dis; 2021 Apr; 72(7):e184-e191. PubMed ID: 33150393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Collateral Effect of COVID-19 on the Epidemiology of Airborne/Droplet-Transmitted Notifiable Infectious Diseases in Taiwan.
    Tang HJ; Lai CC; Chao CM
    Antibiotics (Basel); 2022 Apr; 11(4):. PubMed ID: 35453229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physical interventions to interrupt or reduce the spread of respiratory viruses.
    Jefferson T; Dooley L; Ferroni E; Al-Ansary LA; van Driel ML; Bawazeer GA; Jones MA; Hoffmann TC; Clark J; Beller EM; Glasziou PP; Conly JM
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD006207. PubMed ID: 36715243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of national COVID-19 restrictions on incidence of notifiable communicable diseases in England: an interrupted time series analysis.
    Nash K; Lai J; Sandhu K; Chandan JS; Shantikumar S; Ogunlayi F; Coleman PC
    BMC Public Health; 2022 Dec; 22(1):2318. PubMed ID: 36510205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak in China.
    Lai S; Ruktanonchai NW; Zhou L; Prosper O; Luo W; Floyd JR; Wesolowski A; Santillana M; Zhang C; Du X; Yu H; Tatem AJ
    medRxiv; 2020 Mar; ():. PubMed ID: 32511601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the effectiveness of non-pharmaceutical interventions on influenza during the Coronavirus disease 2019 pandemic by time-series forecasting.
    Kim HK; Min KD; Cho SI
    BMC Infect Dis; 2023 Oct; 23(1):717. PubMed ID: 37875817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interrupted time series analysis using the ARIMA model of the impact of COVID-19 on the incidence rate of notifiable communicable diseases in China.
    Zhou Q; Hu J; Hu W; Li H; Lin GZ
    BMC Infect Dis; 2023 Jun; 23(1):375. PubMed ID: 37316780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Nonpharmaceutical Interventions During the COVID-19 Pandemic With Invasive Pneumococcal Disease, Pneumococcal Carriage, and Respiratory Viral Infections Among Children in France.
    Rybak A; Levy C; Angoulvant F; Auvrignon A; Gembara P; Danis K; Vaux S; Levy-Bruhl D; van der Werf S; Béchet S; Bonacorsi S; Assad Z; Lazzati A; Michel M; Kaguelidou F; Faye A; Cohen R; Varon E; Ouldali N
    JAMA Netw Open; 2022 Jun; 5(6):e2218959. PubMed ID: 35763298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measures implemented in the school setting to contain the COVID-19 pandemic.
    Krishnaratne S; Littlecott H; Sell K; Burns J; Rabe JE; Stratil JM; Litwin T; Kreutz C; Coenen M; Geffert K; Boger AH; Movsisyan A; Kratzer S; Klinger C; Wabnitz K; Strahwald B; Verboom B; Rehfuess E; Biallas RL; Jung-Sievers C; Voss S; Pfadenhauer LM
    Cochrane Database Syst Rev; 2022 Jan; 1(1):CD015029. PubMed ID: 35037252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China.
    Pan A; Liu L; Wang C; Guo H; Hao X; Wang Q; Huang J; He N; Yu H; Lin X; Wei S; Wu T
    JAMA; 2020 May; 323(19):1915-1923. PubMed ID: 32275295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of interventions on the incidence of natural focal diseases during the outbreak of COVID-19 in Jiangsu Province, China.
    Cheng X; Hu J; Luo L; Zhao Z; Zhang N; Hannah MN; Rui J; Lin S; Zhu Y; Wang Y; Yang M; Xu J; Liu X; Yang T; Liu W; Li P; Deng B; Li Z; Liu C; Huang J; Peng Z; Bao C; Chen T
    Parasit Vectors; 2021 Sep; 14(1):483. PubMed ID: 34538265
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perceptions of capacity for infectious disease control and prevention to meet the challenges of dengue fever in the face of climate change: A survey among CDC staff in Guangdong Province, China.
    Tong MX; Hansen A; Hanson-Easey S; Xiang J; Cameron S; Liu Q; Liu X; Sun Y; Weinstein P; Han GS; Williams C; Bi P
    Environ Res; 2016 Jul; 148():295-302. PubMed ID: 27088733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries.
    Li Y; Campbell H; Kulkarni D; Harpur A; Nundy M; Wang X; Nair H;
    Lancet Infect Dis; 2021 Feb; 21(2):193-202. PubMed ID: 33729915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantifying the Impact of COVID-19 Nonpharmaceutical Interventions on Influenza Transmission in the United States.
    Qi Y; Shaman J; Pei S
    J Infect Dis; 2021 Nov; 224(9):1500-1508. PubMed ID: 34551108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.